UK-based Pharmanovia has appointed Béchir Ben Hadj Yahia as global head of medical affairs, as it expands its presence in ...

US biotech Matchpoint Therapeutics today announced the successful closing of a $150 million Series B financing.

Indian pharma major Lupin has launched Formoflo-G MDI, a fixed-dose triple-combination metered-dose inhaler (MDI) for ...

San Diego, USA-based Halozyme Therapeutics announced that it has expanded its global collaboration and license agreement with Dutch immunology company argenx to develop and commercialize ENHANZE with ...

US commercial-stage commercial-stage biotech Rocket Pharmaceuticals announced that it has entered into a credit facility ...

China-based Asieris Pharmaceuticals, which is focused on developing and commercializing innovative therapies for the ...

Some three-quarters of senior biopharma executives expect appetite for partnering and M&A to rise over the next 12 months, and none expect it to fall, according to the inaugural Biopharma C-Suite ...

Julian Beach, Medicines and Healthcare products Regulatory Agency (MHRA) interim executive director of healthcare, quality ...

French hearing loss specialist Sensorion today announced the appointment of Louis “Lou” Arcudi III as chief financial officer ...

China uses two major mechanisms to negotiate medicine prices, offering manufacturers a route to substantial demand in exchange for terms acceptable to public purchasers and insurers. One organizes ...

Cancer drug developers seeking approval in several countries can bring regulators together through Project Orbis, allowing agencies to discuss the same evidence while retaining responsibility for ...

US biotech company ArriVent BioPharma (Nasdaq: AVBP) is reviewing the development path for firmonertinib after its Phase III ...